Soho Flordis International (SFI) is a global natural medicine company committed to identifying and developing leading natural medicines with the best evidence of effectiveness, quality and safety, and marketing them around the world.

SFI is focused on bringing its products to market through healthcare professionals with the endorsement of world class opinion leaders.


SFI is committed to ensuring that people globally have access to quality, innovative evidence based natural medicines. Therefore it is our aim that the safety and efficacy claims for our products are supported by specific clinical evidence. This higher standard enables the selection of safe, appropriate and effective treatments.
View our brands here.


SFI is building an international community of leading herbal and medical companies, experts, scientists and researchers.
View our partners here.


We are committed to further developing the evidence for our products.
View our research programs here.

latest news

Ginsana® celebrates 40th registration anniversary

Thursday, May 26, 2016 - 12:01
Ginsana® celebrated the 40th anniversary of the registration of Ginsana® product.

SFI hosts inaugural Global Equazen™ Partners Meeting

Thursday, May 26, 2016 - 12:00
SFI hosted its inaugural Global Equazen™ Partners Meeting in Wigan, United Kingdom, with attendees representing over 20 countries.

SFI launches Calorease & Pronatal in Jordan

Thursday, May 26, 2016 - 12:00
SFI celebrated the registration of Pronatal and Calorease FBCx in Jordan through a series of launch events with doctors, pharmacist and gynaecologists in Amman.

SFI Korea impresses at BioKorea 2016

Tuesday, April 12, 2016 - 09:30
SFI Korea exhibited the SFI Group product portfolio at this year’s BioKorea 2016 in Seoul, impressing many key industry and government stakeholders at the event.

SFI Research clinical trial receives strong recruitment boost

Tuesday, March 22, 2016 - 16:10
SFI Research’s clinical trial with the Boden Institute at the University of Sydney received a strong recruitment boost, when the trial and the dietary supplements being investigated were covered by Australia’s Channel NINE News.